Herndon Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$128K Hold
743
0.02% 56
2017
Q1
$122K Buy
743
+183
+33% +$30.4K 0.02% 54
2016
Q4
$82K Buy
560
+491
+712% +$73.9K 0.01% 62
2016
Q3
$12K Hold
69
﹤0.01% 168
2016
Q2
$10K Sell
69
-3,008
-98% -$468K ﹤0.01% 186
2016
Q1
$461K Hold
3,077
0.01% 125
2015
Q4
$499K Buy
+3,077
New +$484K 0.01% 129
2014
Q4
Sell
-4,724
Closed -$664K 203
2014
Q3
$664K Sell
4,724
-3,081
-39% -$402K 0.01% 133
2014
Q2
$924K Buy
+7,805
New +$904K 0.01% 132

Other funds holding AMGN

Herndon Capital Management's AMGN Position: Q2 2017 in Review

Herndon Capital Management held its Amgen (AMGN) position steady in Q2 2017 at 743 shares worth $128K. The position accounts for 0.02% of the portfolio, ranked #56.

Herndon Capital Management first reported a position in AMGN in Q2 2014 and has held it in 9 quarters since. The position peaked at $924K in Q2 2014. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Herndon Capital Management held 743 shares of Amgen worth $128K as of Q2 2017.
  • Herndon Capital Management left its Amgen share count unchanged in Q2 2017.
  • Amgen made up 0.02% of Herndon Capital Management's portfolio in Q2 2017, its #56 holding.
  • Herndon Capital Management first reported a position in Amgen in Q2 2014 and has held it in 9 quarters since.
  • Herndon Capital Management's Amgen position peaked at $924K in Q2 2014.
  • 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.